Adrenergic receptors and metabolism: Role in development of cardiovascular disease

Frontiers in Physiology

Volumn 4 OCT, Issue , 2013, Pages

  Ciccarelli, Michele ^a,b   Santulli, Gaetano ^c,d   Pascale, Valeria ^a   Trimarco, Bruno ^d   Iaccarino, Guido ^a,e  

^a UNIVERSITY OF SALERNO   (Italy)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

Beta adrenergic system; Cardiac metabolism; GRKs; Heart failure; Mitochondria

Indexed keywords

ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CARVEDILOL; CATECHOLAMINE; CYCLIC AMP; FATTY ACID; G PROTEIN COUPLED RECEPTOR KINASE 2; GLUCOSE TRANSPORTER 4; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR; METOPROLOL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; CARDIOVASCULAR DISEASE; GLUCOSE TRANSPORT; HEART FAILURE; HEART MUSCLE METABOLISM; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NONHUMAN; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 84885447951     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00265     Document Type: Short Survey

References (57)

1. Ardehali, H., Sabbah, H. N., Burke, M. A., Sarma, S., Liu, P. P., Cleland, J. G., et al. (2012). Targeting myocardial substrate metabolism in heart failure:potential for new therapies. Eur. J. Heart Fail 14, 120-129. doi:10.1161/CIRCRESAHA.112.300754.
2. Banerjee, S., and Peterson, L. R. (2007). Myocardial metabolism and cardiac performance in obesity and insulin resistance. Curr. Cardiol. Rep. 9, 143-149. doi:10.1007/BF02938341.
3. Baruscotti, M., Barbuti, A., and Bucchi, A. (2010). The cardiac pacemaker current. J. Mol. Cell Cardiol. 48, 55-64. doi:10.1016/j.yjmcc.2009.06.019.
4. Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., et al. (2005). Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 1640-1648. doi:10.2337/diabetes.54.6.1640.
5. Belke, D. D., Larsen, T. S., Gibbs, E. M., and Severson, D. L. (2000). Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 279, E1104-E1113.
6. Bing, R. J., Siegel, A., Ungar, I., and Gilbert, M. (1954). Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am. J. Med. 16, 504-515. doi:10.1016/0002-9343(54)90365-4.
7. Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., et al. (2009). Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119, 1272-1283. doi:10.1161/CIRCULATIONAHA.108.792101.
8. Brunn, G. J., Saadi, S., and Platt, J. L. (2006). Differential regulation of endothelial cell activation by complement and interleukin 1alpha. Circ. Res. 98, 793-800. doi:10.1161/01.RES.0000216071.87981.16.
9. Chen, M., Sato, P. Y., Chuprun, J. K., Peroutka, R. J., Otis, N. J., Ibetti, J., et al. (2013). Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting. Circ. Res. 112, 1121-1134. doi:10.1161/CIRCRESAHA.112.300754.
10. Ciccarelli, M., Chuprun, J. K., Rengo, G., Gao, E., Wei, Z., Peroutka, R. J., et al. (2011). G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 123, 1953-1962. doi:10.1161/CIRCULATIONAHA.110.988642.
11. Ciccarelli, M., Sorriento, D., Franco, A., Fusco, A., Del Giudice, C., Annunziata, R., et al. (2013). Endothelial G Protein-Coupled Receptor Kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. Arterioscler. Thromb. Vasc. Biol. 33, 2415-2424. doi:10.1161/ATVBAHA.113.302262.
12. Cipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., et al. (2009). The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cardiovasc. Res. 84, 407-415. doi:10.1093/cvr/cvp252.
13. Eisenhofer, G., Friberg, P., Rundqvist, B., Quyyumi, A. A., Lambert, G., Kaye, D. M., et al. (1996). Cardiac sympathetic nerve function in congestive heart failure. Circulation 93, 1667-1676. doi:10.1161/01.CIR.93.9.1667.
14. Fusco, A., Santulli, G., Sorriento, D., Cipolletta, E., Garbi, C., Dorn, G. W. 2nd., et al. (2012). Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal. 24, 468-475. doi:10.1016/j.cellsig.2011.09.026.
15. Garcia-Guerra, L., Nieto-Vazquez, I., Vila-Bedmar, R., Jurado-Pueyo, M., Zalba, G., Diez, J., et al. (2010). G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 59, 2407-2417. doi:10.2337/db10-0771.
16. Hardie, D. G., Ross, F. A., and Hawley, S. A. (2012). AMPK:a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262. doi:10.1038/nrm3311.
17. Iaccarino, G., Barbato, E., Cipolletta, E., De Amicis, V., Margulies, K. B., Leosco, D., et al. (2005). Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur. Heart J. 26, 1752-1758. doi:10.1093/eurheartj/ehi429.
18. Itani, S. I., Ruderman, N. B., Schmieder, F., and Boden, G. (2002). Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase, C, and IkappaB-alpha. Diabetes 51, 2005-2011. doi:10.2337/diabetes.51.7.2005.
19. Jaber, M., Koch, W. J., Rockman, H., Smith, B., Bond, R. A., Sulik, K. K., et al. (1996). Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. U.S.A. 93, 12974-12979. doi:10.1073/pnas.93.23.12974.
20. Jo, S. H., Leblais, V., Wang, P. H., Crow, M. T., and Xiao, R. P. (2002). Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ. Res. 91, 46-53. doi:10.1161/01.RES.0000024115.67561.54.
21. Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R. A., Bond, R. A., Milano, C. A., et al. (1995). Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268, 1350-1353. doi:10.1126/science.7761854.
22. Kolwicz, S. C. Jr., and Tian, R. (2009). Metabolic therapy at the crossroad:how to optimize myocardial substrate utilization? Trends Cardiovasc. Med. 19, 201-207. doi:10.1016/j.tcm.2009.12.005.
23. Kostis, J. B., and Sanders, M. (2005). The association of heart failure with insulin resistance and the development of type 2 diabetes. Am. J. Hypertens. 18, 731-737. doi:10.1016/j.amjhyper.2004.11.038.
24. Li, J., Yan, B., Huo, Z., Liu, Y., Xu, J., Sun, Y., et al. (2010). beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability. J. Physiol. 588, 2987-2998. doi:10.1113/jphysiol.2010.190900.
25. Lommi, J., Kupari, M., and Yki-Jarvinen, H. (1998). Free fatty acid kinetics and oxidation in congestive heart failure. Am. J. Cardiol. 81, 45-50. doi:10.1016/S0002-9149(97)00804-7.
26. Maarbjerg, S. J., Sylow, L., and Richter, E. A. (2011). Current understanding of increased insulin sensitivity after exercise-emerging candidates. Acta Physiol. (Oxf.) 202, 323-335. doi:10.1111/j.1748-1716.2011.02267.x.
27. Mazumder, P. K., O'Neill, B. T., Roberts, M. W., Buchanan, J., Yun, U. J., Cooksey, R. C., et al. (2004). Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53, 2366-2374. doi:10.2337/diabetes.53.9.2366.
28. Mongillo, M., John, A. S., Leccisotti, L., Pennell, D. J., and Camici, P. G. (2007). Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart. Eur. J. Nucl. Med. Mol. Imaging 34, 1172-1177. doi:10.1007/s00259-007-0371-z.
29. Neubauer, S. (2007). The failing heart-an engine out of fuel. N. Engl. J. Med. 356, 1140-1151. doi:10.1056/NEJMra063052.
30. Neubauer, S., Krahe, T., Schindler, R., Horn, M., Hillenbrand, H., Entzeroth, C., et al. (1992). 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86, 1810-1818. doi:10.1161/01.CIR.86.6.1810.
31. Nevzorova, J., Bengtsson, T., Evans, B. A., and Summers, R. J. (2002). Characterization of the beta-adrenoceptor subtype involved in mediation of glucose transport in L6 cells. Br. J. Pharmacol. 137, 9-18. doi:10.1038/sj.bjp.0704845.
32. Nevzorova, J., Evans, B. A., Bengtsson, T., and Summers, R. J. (2006). Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. Br. J. Pharmacol. 147, 446-454. doi:10.1038/sj.bjp.0706626.
33. Ngala, R. A., O'Dowd, J., Wang, S. J., Agarwal, A., Stocker, C., Cawthorne, M. A., et al. (2008). Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms. Br. J. Pharmacol. 155, 395-406. doi:10.1038/bjp.2008.244.
34. Nikolaidis, L. A., Poornima, I., Parikh, P., Magovern, M., Shen, Y. T., and Shannon, R. P. (2006). The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. J. Am. Coll. Cardiol. 47, 1871-1881. doi:10.1016/j.jacc.2005.11.082.
35. Opie, L. H., and Sack, M. N. (2002). Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J. Mol. Cell. Cardiol. 34, 1077-1089. doi:10.1006/jmcc.2002.2066.
36. Opie, L. H., Thandroyen, F. T., Muller, C., and Bricknell, O. L. (1979). Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. J. Mol. Cell. Cardiol. 11, 1073-1094. doi:10.1016/0022-2828(79)90395-X.
37. Paolisso, G., De Riu, S., Marrazzo, G., Verza, M., Varricchio, M., and D'Onofrio, F. (1991). Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40, 972-977. doi:10.1016/0026-0495(91)90075-8.
38. Perez-Schindler, J., Philp, A., Baar, K., and Hernandez-Cascales, J. (2011). Regulation of contractility and metabolic signaling by the beta2-adrenergic receptor in rat ventricular muscle. Life Sci. 88, 892-897. doi:10.1016/j.lfs.2011.03.020.
39. Peterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., et al. (2004a). Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109, 2191-2196. doi:10.1161/01.CIR.0000127959.28627.F8.
40. Peterson, L. R., Waggoner, A. D., Schechtman, K. B., Meyer, T., Gropler, R. J., Barzilai, B., et al. (2004b). Alterations in left ventricular structure and function in young healthy obese women:assessment by echocardiography and tissue doppler imaging. J. Am. Coll. Cardiol. 43, 1399-1404. doi:10.1016/j.jacc.2003.10.062.
41. Philipson, L. H. (2002). beta-Agonists and metabolism. J. Allergy Clin. Immunol. 110:S313-S317. doi:10.1067/mai.2002.129702.
42. Sakamoto, K., and Holman, G. D. (2008). Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 295, E29-E37. doi:10.1152/ajpendo.90331.2008.
43. Santomauro, A. T., Boden, G., Silva, M. E., Rocha, D. M., Santos, R. F., Ursich, M. J., et al. (1999). Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48, 1836-1841. doi:10.2337/diabetes.48.9.1836.
44. Sasaoka, T., Wada, T., and Tsuneki, H. (2006). Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Pharmacol. Ther. 112, 799-809. doi:10.1016/j.pharmthera.2006.06.001.
45. Semeniuk, L. M., Kryski, A. J., and Severson, D. L. (2002). Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 283, H976-H982.
46. Shahid, G., and Hussain, T. (2007). GRK2 negatively regulates glycogen synthesis in mouse liver FL83B cells. J. Biol. Chem. 282, 20612-20620. doi:10.1074/jbc.M700744200.
47. Stanley, W. C., Recchia, F. A., and Lopaschuk, G. D. (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129. doi:10.1152/physrev.00006.2004.
48. Taylor, M., Wallhaus, T. R., Degrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J., et al. (2001). An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with congestive heart failure. J. Nucl. Med. 42, 55-62.
49. Usui, I., Imamura, T., Babendure, J. L., Satoh, H., Lu, J. C., Hupfeld, C. J., et al. (2005). G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol. Endocrinol. 19, 2760-2768. doi:10.1210/me.2004-0429.
50. Wagenmakers, A. J., van Riel, N. A., Frenneaux, M. P., and Stewart, P. M. (2006). Integration of the metabolic and cardiovascular effects of exercise. Essays Biochem. 42, 193-210. doi:10.1042/bse0420193.
51. Wisneski, J. A., Gertz, E. W., Neese, R. A., and Mayr, M. (1987). Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J. Clin. Invest. 79, 359-366. doi:10.1172/JCI112820.
52. Witteles, R. M., Tang, W. H., Jamali, A. H., Chu, J. W., Reaven, G. M., and Fowler, M. B. (2004). Insulin resistance in idiopathic dilated cardiomyopathy:a possible etiologic link. J. Am. Coll. Cardiol. 44, 78-81. doi:10.1016/j.jacc.2004.03.037.
53. Woo, A. Y., and Xiao, R. P. (2012). beta-Adrenergic receptor subtype signaling in heart:from bench to bedside. Acta Pharmacol. Sin. 33, 335-341. doi:10.1038/aps.2011.201.
54. Zhang, W., Yano, N., Deng, M., Mao, Q., Shaw, S. K., and Tseng, Y. T. (2011). beta-Adrenergic receptor-PI3K signaling crosstalk in mouse heart:elucidation of immediate downstream signaling cascades. PLoS ONE 6:e26581. doi:10.1371/journal.pone.0026581.
55. Zhu, W., Petrashevskaya, N., Ren, S., Zhao, A., Chakir, K., Gao, E., et al. (2011). Gi-biased beta2AR signaling links GRK2 upregulation to heart failure. Circ. Res. 110, 265-274. doi:10.1161/CIRCRESAHA.111.253260.
56. Zhu, W. Z., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., and Xiao, R. P. (2001). Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 98, 1607-1612. doi:10.1073/pnas.98.4.1607.
57. Zucker, I. H. (2006). Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48, 1005-1011. doi:10.1161/01.HYP.0000246614.47231.25.